PL442899A1 - Nowy peptyd penetrujący oraz jego zastosowanie - Google Patents

Nowy peptyd penetrujący oraz jego zastosowanie

Info

Publication number
PL442899A1
PL442899A1 PL442899A PL44289922A PL442899A1 PL 442899 A1 PL442899 A1 PL 442899A1 PL 442899 A PL442899 A PL 442899A PL 44289922 A PL44289922 A PL 44289922A PL 442899 A1 PL442899 A1 PL 442899A1
Authority
PL
Poland
Prior art keywords
sub
application
penetrating peptide
new penetrating
new
Prior art date
Application number
PL442899A
Other languages
English (en)
Other versions
PL247778B1 (pl
Inventor
Konrad Hus
Aleksandra Bocian
Ewa Ciszkowicz
Katarzyna Lecka-Szlachta
Justyna Buczkowicz
Andrzej Łyskowski
Anna Miłoś
Original Assignee
Politechnika Rzeszowska im. Ignacego Łukasiewicza
Podkarpackie Centrum Innowacji Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Rzeszowska im. Ignacego Łukasiewicza, Podkarpackie Centrum Innowacji Spółka Z Ograniczoną Odpowiedzialnością filed Critical Politechnika Rzeszowska im. Ignacego Łukasiewicza
Priority to PL442899A priority Critical patent/PL247778B1/pl
Publication of PL442899A1 publication Critical patent/PL442899A1/pl
Publication of PL247778B1 publication Critical patent/PL247778B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Przedmiotem zgłoszenia jest nowy peptyd penetrujący o wzorze chemicznym C<sub>80</sub>H<sub>140</sub>N<sub>20</sub>O<sub>17</sub>S<sub>2</sub> i o sekwencji LKCKKLIPLFSKTCP, który jest zabezpieczony amidem na końcu C. Zgłoszenie obejmuje także zastosowanie tego nowego peptydu penetrującego jako nośnika leków cytotoksycznych, insuliny, izotopów stosowanych w leczeniu chorób nowotworowych lub nośników środków obrazujących.
PL442899A 2022-11-22 2022-11-22 Nowy peptyd penetrujący oraz jego zastosowanie PL247778B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL442899A PL247778B1 (pl) 2022-11-22 2022-11-22 Nowy peptyd penetrujący oraz jego zastosowanie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL442899A PL247778B1 (pl) 2022-11-22 2022-11-22 Nowy peptyd penetrujący oraz jego zastosowanie

Publications (2)

Publication Number Publication Date
PL442899A1 true PL442899A1 (pl) 2024-05-27
PL247778B1 PL247778B1 (pl) 2025-09-01

Family

ID=91227480

Family Applications (1)

Application Number Title Priority Date Filing Date
PL442899A PL247778B1 (pl) 2022-11-22 2022-11-22 Nowy peptyd penetrujący oraz jego zastosowanie

Country Status (1)

Country Link
PL (1) PL247778B1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018080147A (ja) * 2016-11-18 2018-05-24 東亞合成株式会社 抗腫瘍ペプチドおよびその利用
US20180243441A1 (en) * 2015-03-04 2018-08-30 Agency For Science, Technology And Research Cytotoxic hexim1 peptides and uses thereof
KR20220142954A (ko) * 2021-04-15 2022-10-24 한국생명공학연구원 세포 투과 펩티드, 항암 펩티드 및 이를 포함하는 암 예방 또는 치료용 약학적 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180243441A1 (en) * 2015-03-04 2018-08-30 Agency For Science, Technology And Research Cytotoxic hexim1 peptides and uses thereof
JP2018080147A (ja) * 2016-11-18 2018-05-24 東亞合成株式会社 抗腫瘍ペプチドおよびその利用
KR20220142954A (ko) * 2021-04-15 2022-10-24 한국생명공학연구원 세포 투과 펩티드, 항암 펩티드 및 이를 포함하는 암 예방 또는 치료용 약학적 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XIE, J. I INN.: "REVIEW article, Frontiers in Pharmacology., 20 May 2020, Sec. Experimental Pharmacology and Drug Discovery, Vol. 11 – 2020", CELL-PENETRATING PEPTIDES IN DIAGNOSIS AND TREATMENT OF HUMAN DISEASES: FROM PRECLINICAL RESEARCH TO CLINICAL APPLICATION *

Also Published As

Publication number Publication date
PL247778B1 (pl) 2025-09-01

Similar Documents

Publication Publication Date Title
JP2004534850A5 (pl)
CY1117656T1 (el) Επιλογες θεραπειας για τη νοσο του fabry
ATE442379T1 (de) Bildgebende agentien auf basis bizyklischer peptide
DE59309786D1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
BRPI0405620A (pt) Faixa gástrica mecanicamente ajustável
HUP0300684A2 (hu) Szomatosztatin analógok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
PA8595001A1 (es) Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
UY27721A1 (es) Anticuerpos humanizados que reconocen el peptido amiloide beta.
DK0583421T3 (da) Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse
BR112023006531A2 (pt) Inibidores heterocílicos de egfr e/ou her2, para uso no tratamento de câncer
PL376176A1 (pl) Stały preparat
DE602004021722D1 (de) Bei tumorbildgebung und krebsbehandlung als trägermittel für pharmazeutische verbindungen eingesetzte autoantikörper
MXPA05011233A (es) Vectores peptidicos.
ZA947957B (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active in neurotensin their preparation and pharmaceutical compositions containing them
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
MX2024005237A (es) Compuesto que tiene actividad de degradacion de la proteina btk, y usos medicos del mismo.
PL442899A1 (pl) Nowy peptyd penetrujący oraz jego zastosowanie
PL442959A1 (pl) Nowy peptyd penetrujący komórki oraz jego zastosowanie
BR112020008375A2 (pt) métodos de reduzir efeitos colaterais de terapia conjugada com fármacos de anticorpo anti-cd30
EA202090558A1 (ru) Схемы лечения
DE50114335D1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
TR200101090T2 (tr) Sertralin ağız konsantratı
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도